HEMOSTASIS COAGULATION ROUTINE REAGENTS LYOPHILIZED IMMUNODEPLETED DEFICIENT PLASMAS INTRINSIC PATHWAY FACTOR VIII
Factor VIII Deficient Plasma, immunads.
Factor VIII deficient plasma immunads. is used in the determination of Coagulation Factor VIII by one-stage method based on the Activated Partial Thromboplastin Time (aPTT).
The Factor VIII deficient plasma immunads. is an immune-adsorbed lyophilised, stabilised human plasma with a Factor VIII content of <1%, prepared from HIV 1/2 Ab and HCV Ab negative plasma (see package label and vial label).
Informations
Factor VIII is a glycoprotein synthesized primarily by the liver.
It circulates in plasma in a VWF-bound form that protects it from rapid proteolytic degradation.
It is activated by FXa or thrombin in FVIIIa which will be complexed with FIXa in the presence of phospholipids to activate FX in FXa. A patient with FVIII deficiency has hemophilia A.
Documentation
Download the product sheetPrice list, safety data sheets and notices are accessible to our registered customers.
Lyophilized plasmas
References
4-5154004 | Kit | 50 x 1.0 mL |
4-5154002 | Kit | 5 x 1.0 mL |